NO803136L - Fremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater - Google Patents

Fremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater

Info

Publication number
NO803136L
NO803136L NO803136A NO803136A NO803136L NO 803136 L NO803136 L NO 803136L NO 803136 A NO803136 A NO 803136A NO 803136 A NO803136 A NO 803136A NO 803136 L NO803136 L NO 803136L
Authority
NO
Norway
Prior art keywords
hydroxylkylpenicillanic
6beta
procedure
preparation
acid derivatives
Prior art date
Application number
NO803136A
Other languages
English (en)
Other versions
NO159019C (no
NO159019B (no
Inventor
Michael Stephen Kellogg
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO803136L publication Critical patent/NO803136L/no
Publication of NO159019B publication Critical patent/NO159019B/no
Publication of NO159019C publication Critical patent/NO159019C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04—Preparation
    • C07D499/08—Modification of a carboxyl radical directly attached in position 2, e.g. esterification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/74—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with carbocyclic rings directly attached to the carboxamido radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO803136A 1979-10-22 1980-10-21 Analogifremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater. NO159019C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/086,864 US4287181A (en) 1979-10-22 1979-10-22 Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors

Publications (3)

Publication Number Publication Date
NO803136L true NO803136L (no) 1981-04-23
NO159019B NO159019B (no) 1988-08-15
NO159019C NO159019C (no) 1988-11-23

Family

ID=22201393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO803136A NO159019C (no) 1979-10-22 1980-10-21 Analogifremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater.

Country Status (38)

Country Link
US (1) US4287181A (no)
JP (2) JPS5665892A (no)
KR (1) KR840000797B1 (no)
AR (1) AR227164A1 (no)
AT (2) AT369372B (no)
AU (1) AU519578B2 (no)
BE (1) BE885812A (no)
BG (2) BG35189A3 (no)
CA (2) CA1144159A (no)
CH (2) CH646175A5 (no)
CS (2) CS219291B2 (no)
DD (1) DD154542A5 (no)
DE (1) DE3039504C2 (no)
DK (1) DK389480A (no)
ES (1) ES496166A0 (no)
FI (1) FI71156C (no)
FR (1) FR2467852A1 (no)
GB (3) GB2061930B (no)
GR (1) GR70714B (no)
GT (1) GT198065892A (no)
HU (1) HU183236B (no)
IE (3) IE51026B1 (no)
IL (1) IL61307A (no)
IN (1) IN154918B (no)
IT (1) IT1149259B (no)
LU (1) LU82880A1 (no)
MX (1) MX6094E (no)
NL (1) NL183358C (no)
NO (1) NO159019C (no)
NZ (1) NZ195307A (no)
PH (5) PH16219A (no)
PL (2) PL129534B1 (no)
PT (1) PT71946B (no)
RO (2) RO81225B (no)
SE (1) SE451455B (no)
SU (2) SU1122227A3 (no)
YU (2) YU41743B (no)
ZA (1) ZA806452B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49770B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use
US4444687A (en) * 1981-06-08 1984-04-24 Bristol-Myers Company 2β-Chloromethyl-2α-methylpenam-3α-carboxylic acid sulfone methylene diol mixed esters
ZA826687B (en) * 1981-09-14 1983-07-27 Pfizer Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl 5(r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
US4351840A (en) 1981-09-18 1982-09-28 Pfizer Inc. Antibacterial esters of resorcinol with ampicillin and penicillanic acid 1,1-dioxide derivatives
JPS58109490A (ja) * 1981-12-21 1983-06-29 Sankyo Co Ltd ペニシリン誘導体
RO87705A (ro) * 1982-01-11 1985-10-31 Pfizer Inc,Us Procedeu pentru prepararea unor derivati ai acidului 6-aminoalchilpenicilanic 1,1-dioxid
US4452796A (en) * 1982-06-14 1984-06-05 Pfizer Inc. 6-Aminoalkylpenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
US4377590A (en) * 1982-05-10 1983-03-22 Pfizer Inc. Derivatives of ampicillin and amoxicillin with beta-lactamase inhibitors
US4499017A (en) * 1983-06-06 1985-02-12 Pfizer Inc. Beta-lactamase inhibiting 6-(alkoxyamino-methyl) penicillanic acid 1,1-dioxide and derivatives
US4588527A (en) * 1983-06-06 1986-05-13 Pfizer Inc. Process for preparing penicillanic acid 1,1-dioxide derivatives
US4536393A (en) * 1983-06-06 1985-08-20 Pfizer Inc. 6-(Aminomethyl)penicillanic acid 1,1-dioxide esters and intermediates therefor
US4502990A (en) * 1983-06-06 1985-03-05 Pfizer Inc. Process for 6-(aminomethyl)penicillanic acid 1,1-dioxide and derivatives thereof
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0150984B1 (en) * 1984-01-30 1991-09-11 Pfizer Inc. 6-(substituted) methylenepenicillanic and 6-(substituted) hydroxymethylpenicillanic acids and derivatives thereof
US5015473A (en) * 1984-01-30 1991-05-14 Pfizer Inc. 6-(substituted)methylenepenicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
DD247677A5 (de) * 1984-01-30 1987-07-15 ������@���Kk�� Verfahren zur herstellung von 6-(subst.)-methylenpenicillan- und 6-(subst.)-hydroxymehtylpenicillansaeure und deren derivaten
US4826833A (en) * 1984-01-30 1989-05-02 Pfizer Inc. 6-(Substituted)methylene-penicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
US4503040A (en) * 1984-02-27 1985-03-05 Pfizer Inc. 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors
US4847247A (en) * 1984-07-30 1989-07-11 Merck & Co., Inc. Penicillin derivatives as anti-inflammatory and antidegenerative agents
US4590073A (en) * 1984-10-22 1986-05-20 Pfizer Inc. 6-substituted penicillanic acid 1,1-dioxide compounds
US4591459A (en) * 1984-12-03 1986-05-27 Pfizer Inc. Intermediates for 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides
US4762921A (en) * 1985-04-18 1988-08-09 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
US4675186A (en) 1985-04-18 1987-06-23 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
US4613462A (en) * 1985-07-02 1986-09-23 Pfizer, Inc. 6-substituted penicillanic acid 1,1-dioxide compounds
US4782050A (en) * 1987-01-27 1988-11-01 Pfizer Inc. 6-beta(substituted)-(S)-hydroxymethylpenicillanic acids and derivatives thereof
DE3869630D1 (de) * 1987-01-27 1992-05-07 Pfizer 6-beta(substituierte)-(s)-hydroxymethylpenicillansaeure und deren derivate.
US6395726B1 (en) 1999-01-26 2002-05-28 American Cyanamid Company 3,6-disubstituted penam sulfone derivatives
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
CA2528065A1 (en) * 2003-06-05 2004-12-16 Pfizer Products Inc. Beta-lactamase inhibitor prodrug
US8293893B2 (en) * 2007-03-09 2012-10-23 Otsuka Chemical Co., Ltd. Method for producing 6-hydroxyethylpenam compound
CN109422765B (zh) * 2017-09-05 2020-08-28 香港理工大学深圳研究院 C类β-内酰胺酶抑制剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5749555B2 (no) * 1973-04-04 1982-10-22
US4207323A (en) * 1975-11-21 1980-06-10 Merck & Co., Inc. 6-Substituted methyl penicillins, derivatives and analogues thereof
US4053468A (en) * 1976-02-25 1977-10-11 Smithkline Corporation Process for preparing 7-oxo cephalosporins and 6-oxo penicillins
US4093625A (en) * 1976-08-09 1978-06-06 Massachusetts Institute Of Technology 6-Sulfur analogs of penicillins and cephalosporins
US4123539A (en) * 1977-12-29 1978-10-31 Merck & Co., Inc. 6-Ethylpenicillanic acid
US4272439A (en) * 1978-06-02 1981-06-09 Schering Corporation 6-(Substituted-hydroxymethylene penams)
JPS5598186A (en) * 1979-01-10 1980-07-25 Beecham Group Ltd Manufacture of penicillin derivative
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use

Also Published As

Publication number Publication date
JPS5665892A (en) 1981-06-03
CH646175A5 (fr) 1984-11-15
RO86176B (ro) 1985-03-31
PL129638B1 (en) 1984-05-31
IE51026B1 (en) 1986-09-17
KR840000797B1 (ko) 1984-06-12
RO86176A (ro) 1985-03-15
NL8005810A (nl) 1981-04-24
JPS6135197B2 (no) 1986-08-12
FR2467852B1 (no) 1983-10-07
GB2129421B (en) 1984-11-14
ES8204437A1 (es) 1982-05-01
PL129534B1 (en) 1984-05-31
GB2061930A (en) 1981-05-20
BG38639A3 (en) 1986-01-15
YU41743B (en) 1987-12-31
JPS61178988A (ja) 1986-08-11
SE451455B (sv) 1987-10-12
GB2061930B (en) 1984-06-13
IE51028B1 (en) 1986-09-17
SE8007354L (sv) 1981-04-23
ES496166A0 (es) 1982-05-01
SU1122227A3 (ru) 1984-10-30
KR830004309A (ko) 1983-07-09
GB8316829D0 (en) 1983-07-27
GB8316830D0 (en) 1983-07-27
DE3039504A1 (de) 1981-04-30
RO81225A (ro) 1983-02-15
DK389480A (da) 1981-04-23
FI71156C (fi) 1986-11-24
GB2128986B (en) 1985-06-19
PH17315A (en) 1984-07-20
PL227420A1 (no) 1982-08-30
GR70714B (no) 1983-01-18
PH16219A (en) 1983-08-09
AU519578B2 (en) 1981-12-10
CS219291B2 (en) 1983-03-25
YU267680A (en) 1983-09-30
IE850293L (en) 1981-04-22
ATA518580A (de) 1982-05-15
ATA10882A (de) 1983-09-15
FI803311L (fi) 1981-04-23
NZ195307A (en) 1984-08-24
PH18316A (en) 1985-05-29
IL61307A (en) 1984-03-30
IL61307A0 (en) 1980-12-31
IT8025488A0 (it) 1980-10-21
NO159019C (no) 1988-11-23
GB2129421A (en) 1984-05-16
IN154918B (no) 1984-12-22
GT198065892A (es) 1982-04-10
HU183236B (en) 1984-04-28
BE885812A (fr) 1981-04-21
PL235907A1 (no) 1982-09-13
PH17317A (en) 1984-07-20
CH647242A5 (fr) 1985-01-15
US4287181A (en) 1981-09-01
FR2467852A1 (fr) 1981-04-30
FI71156B (fi) 1986-08-14
YU42075B (en) 1988-04-30
YU67183A (en) 1984-02-29
DD154542A5 (de) 1982-03-31
AR227164A1 (es) 1982-09-30
ZA806452B (en) 1981-10-28
PT71946B (en) 1981-08-31
IE802174L (en) 1981-04-22
LU82880A1 (fr) 1981-06-04
NL183358B (nl) 1988-05-02
AU6354880A (en) 1981-04-30
SU1026654A3 (ru) 1983-06-30
IE51027B1 (en) 1986-09-17
MX6094E (es) 1984-11-12
AT369372B (de) 1982-12-27
PT71946A (en) 1980-11-01
AT374479B (de) 1984-04-25
CA1163924A (en) 1984-03-20
CS219292B2 (en) 1983-03-25
IT1149259B (it) 1986-12-03
IE852229L (en) 1981-04-22
RO81225B (ro) 1983-02-28
DE3039504C2 (de) 1984-10-11
CA1144159A (en) 1983-04-05
BG35189A3 (en) 1984-02-15
GB2128986A (en) 1984-05-10
NL183358C (nl) 1988-10-03
PH17458A (en) 1984-08-29
NO159019B (no) 1988-08-15

Similar Documents

Publication Publication Date Title
NO803136L (no) Fremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater
NO801415L (no) Fremgangsmaate for fremstilling av antibakterielt aktive bisestere av metandiol med penicillinderivater
NO800626L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater
NO784397L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO151966C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazol-5-eddiksyrederivater
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO854260L (no) Fremgangsmaate for fremstilling av (d-alfa-amino-(p-hydroksyfenylacetamido)) gruppeholdige cefalosporansyrederivater
NO810762L (no) Fremgangsmaate for fremstilling av farmakologisk aktive heterocykliske forbindelser
NO771578L (no) Fremgangsmaate for fremstilling av di-n-propyleddiksyre
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
FI803025A (fi) Foerfarande foer framstaellning av farmakologiskt aktiva ergolinderivat
NO802015L (no) Fremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO794317L (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
NO151500C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater
NO150799C (no) Fremgangsmaate for fremstilling av lysergol-derivater
NO772329L (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive imidazolinderivater
NO146356C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO780743L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner
SE421787B (sv) Forfarande for framstellning av kvadratsyra
NO803115L (no) Fremgangsmaate for fremstilling av stivelselim